1. Home
  2. AROC vs KYMR Comparison

AROC vs KYMR Comparison

Compare AROC & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Archrock Inc.

AROC

Archrock Inc.

HOLD

Current Price

$37.50

Market Cap

6.1B

Sector

Energy

ML Signal

HOLD

Logo Kymera Therapeutics Inc.

KYMR

Kymera Therapeutics Inc.

HOLD

Current Price

$84.99

Market Cap

6.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AROC
KYMR
Founded
1990
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Medicinal Chemicals and Botanical Products
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.1B
6.8B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
AROC
KYMR
Price
$37.50
$84.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
26
Target Price
$40.00
$107.72
AVG Volume (30 Days)
1.3M
507.7K
Earning Date
05-05-2026
04-30-2026
Dividend Yield
2.43%
N/A
EPS Growth
74.29
N/A
EPS
1.83
N/A
Revenue
$1,489,818,000.00
$39,211,000.00
Revenue This Year
$7.06
$10.61
Revenue Next Year
$5.27
$8.17
P/E Ratio
$19.71
N/A
Revenue Growth
28.70
N/A
52 Week Low
$21.17
$28.06
52 Week High
$37.73
$103.00

Technical Indicators

Market Signals
Indicator
AROC
KYMR
Relative Strength Index (RSI) 62.34 48.45
Support Level $34.30 $77.78
Resistance Level N/A $90.15
Average True Range (ATR) 1.07 3.06
MACD 0.04 -0.18
Stochastic Oscillator 92.94 29.50

Price Performance

Historical Comparison
AROC
KYMR

About AROC Archrock Inc.

Archrock Inc is an energy infrastructure company focused on midstream natural gas compression. It is a provider of natural gas compression services, based on total compression fleet horsepower, to customers across the United States and a supplier of aftermarket services to customers that own compression equipment. The company operates through two segments: contract operations and aftermarket services. The contract operations segment includes designing, sourcing, owning, installing, operating, servicing, repairing, and maintaining its owned fleet of natural gas compression equipment, and generates the maximum revenue. The aftermarket services segment provides operations, maintenance, overhaul, and reconfiguration services, and sales of parts and components.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: